Document ID: chunk:federal_register_of_legislation:F2022L01117:reg:7
Version: federal_register_of_legislation:F2022L01117
Segment Type: reg
Provision Reference: reg 7
Character Range: 1782–3430

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about mature B-cell lymphoid leukaemia and small lymphocytic lymphoma and death from mature B-cell lymphoid leukaemia and small lymphocytic lymphoma.
Meaning of mature B-cell lymphoid leukaemia and small lymphocytic lymphoma
(2)          For the purposes of this Statement of Principles, mature B-cell lymphoid leukaemia and small lymphocytic lymphoma:
(a)          means a malignant neoplasm characterised by the clonal proliferation of small morphologically mature, non-functioning lymphoid cells of B-cell origin, which can present clinically as either a leukaemia or a lymphoma; and
(b)          includes:
(i)            B-cell prolymphocytic leukaemia;
(ii)         chronic lymphocytic leukaemia/small lymphocytic lymphoma; and
(iii)       hairy cell leukaemia; and
(c)          excludes non-Hodgkin lymphoma other than small lymphocytic lymphoma.
               Note: Small lymphocytic lymphoma and chronic lymphocytic leukaemia are tumours of the same lymphoid cell type, and are considered to be a single disease entity with two clinical presentations.
Death from mature B-cell lymphoid leukaemia and small lymphocytic lymphoma
(3)          For the purposes of this Statement of Principles, mature B-cell lymphoid leukaemia and small lymphocytic lymphoma, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's mature B-cell lymphoid leukaemia and small lymphocytic lymphoma.
Note: terminal event is defined in the Schedule 1 – Dictionary.